Ralf Schmid
Independent Expert Independent Expert
Ralf Schmid is an independent expert specializing in the preclinical development of AAV gene therapies, RNAi/ASO platforms, and gene editing technologies. He provides strategic guidance on therapeutic innovation through deep-dive analyses of competitive landscapes and unmet clinical needs. His prior leadership roles include Associate Director at Novartis Neuroscience Genetic Medicines and Research Director at the University of Pennsylvania’s Gene Therapy Program.
Seminars
Tuesday 24th March 2026
Panel Discussion: Scaling Clinical Operations to Support Gene Therapies for Larger Populations
9:00 am
- Highlighting the limitations of current small-batch methods in meeting the needs of larger patient populations
- Understanding the unique manufacturing, financial, and regulatory challenges associated with working on common disease indications
- Anticipating the scientific and operational shifts needed to make gene therapy viable for high-prevalence conditions
